Shares of WELL Health Technologies Corp. (TSE:WELL – Get Rating) have been assigned an average rating of "Buy" from the eight research firms that are presently covering the stock, MarketBeat.com reports. Five investment analysts have rated the stock with a buy rating. The average twelve-month target price among brokers that have covered the stock in the last year is C$9.38.
A number of research firms recently weighed in on WELL. TD Securities lifted their price target on WELL Health Technologies from C$7.00 to C$8.00 and gave the company a "buy" rating in a research note on Friday, August 12th. Scotiabank decreased their price target on WELL Health Technologies from C$9.00 to C$7.50 in a research note on Friday, May 20th. CIBC lifted their price target on WELL Health Technologies from C$6.50 to C$7.50 in a research note on Monday, August 15th. Finally, Canaccord Genuity Group decreased their price target on WELL Health Technologies from C$10.00 to C$6.00 in a research note on Friday, May 20th.
Get WELL Health Technologies alerts:WELL Health Technologies Trading Up 3.2 %
Shares of WELL stock opened at C$3.84 on Friday. The business's 50 day moving average is C$3.45 and its two-hundred day moving average is C$4.02. WELL Health Technologies has a twelve month low of C$2.98 and a twelve month high of C$8.25. The company has a market capitalization of C$870.66 million and a P/E ratio of -17.53. The company has a current ratio of 1.14, a quick ratio of 1.04 and a debt-to-equity ratio of 47.93.
WELL Health Technologies Company Profile
(Get Rating)WELL Health Technologies Corp. operates as a practitioner focused digital health company in Canada, the United States, and internationally. It offers end-to-end omni-channel patient services, including primary care; physiotherapy, occupational therapy, chiropractic, dietary, mental health counselling, and sleep related services; specialized care, including gastroenterologists; diagnostic services related to cardiology, women's health, and bone/muscle health and cancer diagnostics; and telehealth services.
See Also
- Should AbbVie Inc. Have a Place in Your Dividend Portfolio?
- Is PayPal A Buy After Post-Earnings Price Jump?
- Williams-Sonoma's High-End Consumers Are Still Spending
- Snowflake Stock Soars On Strong Results
- ShockWave Stuns With 40% Post-Earnings Price Move: Is It A Buy?
Receive News & Ratings for WELL Health Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WELL Health Technologies and related companies with MarketBeat.com's FREE daily email newsletter.